key: cord-1015263-cu5ke2b4
authors: Forni, Diego; Cagliani, Rachele; Pontremoli, Chiara; Mozzi, Alessandra; Pozzoli, Uberto; Clerici, Mario; Sironi, Manuela
title: Antigenic variation of SARS-CoV-2 in response to immune pressure
date: 2020-07-15
journal: bioRxiv
DOI: 10.1101/2020.07.15.204610
sha: e9ecff14eed388d3ac7e21e34f6292928a791ae3
doc_id: 1015263
cord_uid: cu5ke2b4

The ongoing evolution of SARS-CoV-2 is expected to be at least partially driven by the selective pressure imposed by the human immune system. We exploited the availability of a large number of high-quality SARS-CoV-2 genomes, as well as of validated epitope predictions, to show that B cell epitopes in the spike glycoprotein (S) and in the nucleocapsid protein (N) have higher diversity than non-epitope positions. Similar results were obtained for other human coronaviruses. Conversely, in the SARS-CoV-2 population, epitopes for CD4+ and CD8+ T cells were not more variable than non-epitope positions. A significant reduction in epitope variability was instead observed for some of the most immunogenic proteins (S, N, ORF8, and ORF3a). Analysis over longer evolutionary time-frames indicated that this effect is not due to differential constraints. These data indicate that SARS-CoV-2 is evolving to elude the host humoral immune response, whereas recognition by T cells might benefit the virus.

Overall, these data indicate that T cell epitopes in the most immunogenic SARS-CoV-2 proteins (S, N, 135

ORF3a, and ORF8) (Grifoni et al., 2020b; Peng et al., 2020b) tend to be more conserved than non-136 epitopes. However, this was not the case for other proteins targeted by T cell responses, namely M, 137

ORF7a, nsp3, nsp4, and nsp6. 138

Clearly, protein sequence variability is strongly influenced by functional and structural constraints. We 139 thus reasoned that if the observations reported above were secondary to the incidental co-localization of Given the results above we set out to determine whether the other human coronaviruses show the same 164 tendency of reduced and increased variability at T cell and B cell epitopes, respectively. For these 165 viruses, analyses were restricted to the N and S proteins, as they are the most antigenic proteins and 166 because the number of complete viral genomes is relatively limited (Table S3) Thus, all available S and N sequences were included in the analyses (Table S4) are significantly more variable than non-epitopes for SARS-CoV, HCoV-OC43 and HCoV-HKU1 181 ( Figure 4) . Analysis of CD4 + and CD8 + T cell epitopes in these viruses indicated no increased diversity 9 for epitope compared to non-epitope positions, with the exclusion of the S protein of SARS-CoV for 183 CD4 + T cells. However, when positions within B cell epitopes were excluded from the analysis, this 184 difference disappeared and T cell epitopes were found to be significantly less variable than non-185 epitopes for the spike proteins of HCoV-HKU1 and HCoV-OC43, as well as for the N protein of 186

HCoV-229E ( figure 4) . Thus, the lack of antigenic diversity at T cell epitopes is a common feature of 187 human coronaviruses, which instead tend to maintain sequence conservation of such epitopes. Clearly, gaining insight into the dynamic interaction between SARS-CoV-2 and the human immune 234 system is of fundamental importance not only to understand COVID-19 immunopathogenesis, but also 235 to inform therapeutic and preventive viral control strategies. We thus exploited the availability of a 236 large number of fully sequenced high-quality SARS-CoV-2 genomes, as well as validated predictions 237 of B cell and T cell epitopes, to investigate whether the selective pressure exerted by the adaptive 238 immune response is detectable in global SARS-CoV-2 population, and if the virus is evolving to evade 239 it. Results indicated that B cell epitopes in the N and S proteins, which represent the major targets of 240 the antibody response, have higher diversity than non-epitope positions. The same was observed for the 241 spike proteins of HCoV-HKU1, HCoV-OC43 and SARS-CoV, although data on the latter virus should 242 be taken with caution as they derive from a relatively small number of sequences sampled over a short 243 time frame. Conversely, no evidence of antibody-mediated selective pressure was evident for HCoV-244 229E and HCoV-NL63. The reasons underlying these differences are unclear, but recent data on a 245 relatively small population of patients with respiratory disease indicated that the titers of neutralizing 246 antibodies against HCoV-OC43 tend to be higher compared to those against HCoV-229E and HCoV-247 NL63 (HCoV-HKU1 was not evaluated), suggesting the two latter viruses elicit mainly non-248 neutralizing responses (Gorse et al., 2020). 249 B cell epitopes within nsp16 were also found to be variable, although this protein was not reported to 250 be immunogenic (Grifoni et al., 2020b). However, the antibody response to SARS-CoV-2 has presently 251 been systematically analyzed in a relatively small number of patients and most studies focused on 252 structural proteins. It is thus possible that, during infection, antibodies against nsp16 are raised but they 253 have not been detected yet. An alternative possibility is that B cell epitopes in nsp16, which is highly 254 12 conserved in SARS-CoV-2 strains (Cagliani et al., 2020), coincide with regions of relatively weaker 255 constraint. This hypothesis is partially supported by the observation that these same positions also 256 display higher diversity when entropy is calculated on an alignment of sarbecovirus nsp16 proteins. 257

More intriguingly, this result may indicate that nsp16, together with S and N, is a target of B cell 258 responses in the bat reservoirs. In fact, as mentioned above, antibody binding sites tend to be conserved indicated that, apart from CD4 + T cell epitopes in the N protein, the T cell epitopes predicted in SARS-283

CoV-2 proteins are not less diverse than non-epitope positions, suggesting that epitope conservation is 284 not simply secondary to structural or functional constraints, but may result from interaction with human 285 T cell responses. Of course, another possible explanation for this finding is that the prediction tools 286 failed to identify real epitopes. However, we retrieved epitopes from a previous work and the authors 287 ORF7 did not show differences in T cell epitope conservation, which was instead observed for nsp16 315 and nsp15. These latter are not known to be T cell targets (Grifoni et al., 2020b) . Clearly, further 316 analyses will be required to clarify the significance of T cell epitope conservation in SARS-CoV-2. An 317 interesting possibility is that both for SARS-CoV-2 and for common cold coronaviruses, conservation 318 serves to maintain epitopes that elicit tolerizing T cell responses or induce T cells with regulatory 319 activity. Indeed, we considered T cell epitopes as a whole, but differences exist in terms of variability 320 and, most likely, antigenicity. This clearly represents a limitation of this study, but the modest amount Sequences and alignments 348 349 SARS-CoV-2 protein sequences were downloaded from the GISAID Initiative (https://www.gisaid.org) 350 database (as of June, 5 th ). All protein sequences were retrieved and several filters were applied. Only 351 complete genomes flagged as "high coverage only" and "human" were selected. Positions 352 recommended to be masked by DeMaio and coworkers (https://virological.org/t/masking-strategies-for-353 sars-cov-2-alignments/480, last accessed June, 5 th , 2020) were also removed. 354

Finally, for each SARS-CoV-2 protein, we selected only strains that had the same length as the protein 355 in the SARS-CoV-2 reference strain (NC_045512), generating a set of at least 23625 sequences for 356 each ORF. Proteins with less than 60 amino acids were excluded from the analyses. 357

The list of GISAID IDs along with the list of laboratories which generated the data is provided as Table  358 S5. 359

For all the other human coronaviruses, as well as for a set of non-human infecting sarbecoviruses, 360 sequences of either complete genome or single ORFs (i.e. nucleocapsid and spike protein) were 361 retrieved from the National Center for Biotechnology Information database (NCBI, 362 http://www.ncbi.nlm.nih.gov/). For all human coronaviruses, the only filter we applied was the host 363 identification as "human". SARS-CoV strains sampled during the second outbreak were excluded from 364 the analyses. NCBI ID identifiers are listed as Table S2 and Table S4 . Most positions of analyzed viruses are invariable along the alignments, so the distribution of H is zero-374 inflated. We thus calculated statistical significance by permutations. For each protein, the predicted 375 epitope intervals were collapsed to a single position while non-epitope intervals were left unchanged. 376

After randomly shuffling this collapsed sequence it was expanded back to full length and the difference 377 between shuffled epitope and non-epitope H values was calculated. This procedure was repeated 1000 378 times and the proportion of repetitions showing a difference more extreme than D was reported as p-379

value. An in house R script was written and is available as supplementary text S1. 

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and 591 their implications

Characteristics of and important lessons from the coronavirus 593 disease 2019 (COVID-19) outbreak in china: Summary of a report of 72 314 cases from the chinese 594 center for disease control and prevention

Characterization of the antigen processing machinery and endogenous peptide 597 presentation of a bat MHC class I molecule

Isolation and characterization of 2019-nCoV-like coronavirus from malayan pangolins

Zoonotic origins of human 602 coronaviruses

SARS-CoV-2 spike protein variant D614G 605 increases infectivity and retains sensitivity to antibodies that target the receptor binding domain

Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease 609 severity and outcome for patients with COVID-19

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases 612 infectivity

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clinical Infectious 615 Diseases

A pneumonia outbreak associated with a new coronavirus of probable bat origin

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Epitope positions are shown in dark gray, non-epitopes in light gray